Product Description
Since last manyyears Saintroy Lifescience is leading manufacture, export andsupplier ofPaclitaxel Injectionfrom Surat, Gujarat, India. PaclitaxelInjection used to treat a number of types of cancer.
Tags: Paclitaxel Injection manufacturer, Paclitaxel Injection exporter,Paclitaxel Injection supplier, and Paclitaxel Injection, whogmp approved PaclitaxelInjection manufacturer and supplier, Paclitaxel Injection distributor, PaclitaxelInjection shipper, Paclitaxel Injection 5 ml Paclitaxel Injection 5 ml supplier,Paclitaxel Injection 5 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility inGujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy LifesciencePaclitaxel Injection Exportto USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Comprehensive Oncology SolutionPaclitaxel Injection offers versatile efficacy in the management of multiple solid tumors, providing clinicians and patients with a reliable option for established cancer therapies. Its use in major indications-such as breast, ovarian, and lung cancer-highlights its significance in oncology. The product's single-dose packaging ensures dosing accuracy and reduces contamination risk, making it suitable for medical facilities requiring stringent administration protocols.
Quality Assurance and StorageManufactured by leading pharmaceutical companies in India, Paclitaxel Injection meets rigorous quality standards. The preparation is clear to slightly yellow and should be stored in a cool, dry environment to preserve its effectiveness throughout the two-year shelf life. Proper handling and storage instructions are essential to maintain product stability and ensure optimal patient outcomes during cancer therapy cycles.
FAQ's of Paclitaxel Injection:
Q: How is Paclitaxel Injection 100 mg/16.7 mL administered?
A: Paclitaxel Injection is administered as an intravenous infusion under direct supervision of a healthcare professional experienced in chemotherapy. The dosage and infusion schedule are determined by the treating physician based on the patient's diagnosis and overall condition.
Q: What medical conditions is Paclitaxel Injection commonly used to treat?
A: This medication is indicated primarily for breast cancer, ovarian cancer, non-small cell lung cancer, and Kaposi's sarcoma. It is often part of a broader cancer treatment regimen tailored to each patient's needs.
Q: When should Paclitaxel Injection be used during cancer therapy?
A: Paclitaxel is typically used at specific stages in cancer treatment as decided by the oncologist, often after evaluating the disease progression and response to other therapies. Timing and dosing are set according to established clinical guidelines.
Q: Where should Paclitaxel Injection be stored for best efficacy?
A: The injection should be kept in a cool, dry place, away from sunlight and moisture, to maintain its stability and shelf life. Always follow the manufacturer's storage recommendations to ensure product integrity.
Q: What is the process for administering Paclitaxel Injection safely?
A: Administration involves diluting the vial as per medical guidance and infusing the solution slowly into a vein. Healthcare staff monitor for possible allergic reactions or side effects during and after the infusion.
Q: How does Paclitaxel Injection benefit cancer patients?
A: Paclitaxel disrupts cancer cell division, helping to slow or stop tumor growth. Used as part of combination therapy or alone, it may improve survival rates and quality of life in patients with certain cancers.